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1183-151 Outcomes of Percutaneous Intervention in Cardiac 
Allograft Vaaculopathy 
David M. Casev, Randall C, Starling, Murat Tuzcu, Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Background: In heart transplant patients surviving >1 year after transplantation, cardiac 
allograft vasculopathy (CAV) remains the leading cause of death. Percutaneous interven- 
tion, which has proven effective in native vessel disease, is being increasingly used in 
the treatment of CAV, however the long term clinical and angiographic outcomes are 
largely unknown. 
Methods: Between January 1995 and December 2000, 27 patients at our institution 
underwent percutaneous intervention for 48 coronary lesions. There were 25 slanting 
procedures and 23 psrcutaneous transluminal coronary angioplasty (PTCA) procedures, 
with or without atheroablation. Forty of the lesions were de nova. Routine follow-up 
angiograms were obtained at 12 months; angiography was performed earlier if clinically 
indicated. Restenosis was defined as >50% narrowing of the target vessel segment. 
Data was collected on the clinical endpoints of cardiac death, non-fatal myocardial infarc- 
tion, or need for surgical revascularization. 
Results: Procedural success was 96% (46/48), and there were no major complications. 
Clinical follow-up was available for all 27 patients. One patient died 12 days poststent of 
a cardiac arrest, one patient suffered a nonfatal myocardial infarction 13 months posts- 
tent, and two patients required bypass grafting; one 5 months poststent and the other 12 
months postPTCNatherectomy. No patients were retransplanted. Follow-up angiography 
was available for 78% of the intervened segments. The restenosis rate for all types of 
intervention was 47%(17/36) at a mean follow-up time of 20.4+13.8 months. Restenosis 
was seen in 41%(7/17) of stented lesions and in 53%(10/19) of PTCA lesions, not a sta- 
tistically significant difference. 
Conclusion'=: Percutaneous intervention for the treatment of CAV can be performed 
safely with high procedural success rates. Restenosis rates are higher than what is seen 
in native vessel intervention, however the clinical event rate is low. The restenosis rates 
for PTCA and slant are approximately equivalent. A larger number of patients needs to 
be evaluated to determine the most efficacious approach in using percutaneous interven- 
tion for CAV. 
1183-152 Left Ventricular Systolic Function Early After Heart 
Transplantation Is Related to Subsequent Cardiac 
AIIograft Vasculopathy 
Islam A. Bolad. Derek Robinson, Asghar Khaghani, Nicholas R. Banner, Harefield 
Hospital, Harefield, United Kingdom. 
Background: Cardiac allograft injury at the time of transplantation may be related to 
subsequent cardiac allograft vasculopathy (CAV). We investigated whether the left ven- 
tricular systolic function early after heart transplantation is related to subsequent devel- 
opment of CAV. 
Methods: We measured the echocardiographic left ventricular fractional shortening (FS) 
during the first week after transplantation in 117 patients and performed quantitative cor- 
onary angiography (QCA) within 4 weeks and again 1 year after transplantation. Anglo- 
grams were obtained using a standardised technique after intracoronary GTN. 
Results: Ninety-eight patients were males (83.8%) and 19 were females (16.2%); the 
mean age was 48.4±10.1years. 110 (94%) patients were Caucasian. The cause of the 
heart failure, which necessitated transplantation, was ischaemic in 71(61%) patients, 
idiopathic dilated cardiomyopathy in 28 (24%), congenital in 6 (5%) and other causes in 
12 (10%) patients. The total organ ischaemia time during transplantation was 155±57 
minutes. The outcome measure was loss of absolute lumen diameter determined by 
QCA. The initial FS was 35±7 %, with a median of 35%. The table below shows the 
strong relationship between the FS early after operation and narrowing of the epicardial 
coronary arteries during the first year after transplantation. 
Year initial FS n Mean decrease in diameter (mm) SEM p-value 
0 to 1 _<35% 60 0.290 0.034 0.0098 
0to 1 >35% 57 0.164 0.034 
Conclusion: Improvements in myocardial protection and methods that reduce 
ischaemia-reperfusion injury during transplantation may reduce the risk of subsequent 
CAV. 
1183-171 The Relationship of A I Iogref t  In f lammatory  Factor-1 
(AIF-f) Expression to Rejection Grade in 
Endomyocardial Biopsies From Cardiac Ailograft 
Recipients 
Howard J. Eisen. Shed E. Kelemen, Michael V. Autieri, Temple University School of 
Medicine, Philadelphia, Pennsylvania. 
Background: Cardiac allograft vasculopathy (CAV) is a major sequela of cardiac transplan- 
tation which limits the long time survival of cardiac transplant recipients. The initiation of 
CAV is believed to involve a chronic immune response of the recipient to the donor vascu- 
lature in which activated immune cells damage the endothelium, resulting in the elabora- 
tion of cytokines and modulation of arterial medial vascular smooth muscle cell (VSMC) 
gene expression. These cytokines elicit the activation of VSMCs which migrate into the inti- 
mal layer and proliferate, causing the vascular narrowing seen in CAV. This cytokine- 
induced activation and proliferation of medial VSMCs is one of the most critical cellular 
events in the pathogenesis of CAV. Allograff Inflammatory Factor-1 (AIF-1) is a 147 amino 
acid calcium-binding protein which was originally identified and cloned from rat cardiac 
allografts with chronic rejection. It has previously been shown to be induced in cultured 
human VSMCs stimulated with a variety of inflammatory cytokines. Further, over-expres- 
sion of AIF-1 results in enhanced growth and activation of VSMCs. The relationship of AIF- 
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1 expression to acute cellular rejection is not well understood. Methods: To further explore 
the relationship of AIF-1 gene expression to allograft rejection, we studied 235 endomyo- 
cardial biopsies from 34 cardiac transplant patients for expression of AIF-1 using reverse- 
transcriptase polymerase chain reaction (RT-PCR). GAPDH, a constitutively expressed 
control gene, was used to determine the presence of mRNA in biopsy specimens. Results: 
The percentage of biopsies expressing AIF-1 as a function of ISHLT grade were:Grade 0- 
11/56 (19.6%); Grades 1A and 1B- 24/61 (39.3%); Grade 2- 14/18 (77.8%); Grades 3A 
and 3B- 12121 (57.1%). AIF-1 expression was enhanced with more severe ISHLT rejection 
grades. Conclusion: We conclude that AIF-1 expression is enhanced as a result of cellular 
rejection. This enhanced expression, ff persistent, may link the presence of significant 
ISHLT grade rejection episodes to the subsequent development of CAV. 
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1184-137 Blunted Heart Rate Recovery Fails to Predict Coronary 
Events in Apparently Healthy Individuals 
Jerome L. Fled, Rouzbeh Tehrani, Frances E. O'Connor, Jeanetta G. Wright, National 
Institute on Aging, Baltimore, MD. 
Backaround: Blunted heart rate (HR) recovery from exercise has been shown to predict 
all-cause mortality. However, its effect on cardiac end-points is not known. 
Methods: We analyzed HR recovery from maximal treadmill exercise (modified Balke 
protocol) in 1052 subjects, aged 18-90 yr from the Baltimore Longitudinal Study on Aging 
from 1979 to 1996, were clinically free of heart disease. HR recovery was defined as the 
change in HR between peak exercise and 2 minutes post exercise (AHR2). 
Results: On linear regression analysis, AHR2 correlated inversely with age (r=-0.42), sit- 
ting HR (r=-0.31) and exercise duration (DUR)(r=-0.31), each p<.000t. Over a mean fol- 
low-up of 9.1 _+ 9.6 yr, coronary events (CE), i.e., angina pectoris, myocardial infarction, 
or coronary death, developed in 116 subjects. Those experiencing CE were older (65 -+ 
12 vs 52 ± 17 yr) and had shorter DUR(9.1 ± 2.7 vs 11.0 ± 2.8mini and smaller AHR2 (51 
+- 13 vs 57 +- 13 beats/mini each p<.000t han those who remained event-frae. The inde- 
pendent predictors of CE were determined from a Cox proportional hazards model 
including age, gender, plasma cholesterol (CHOL), hypertension status, smoking status, 
DUR, exercise-induced ischemic ST segment depression (ST-D)and AHR2 (Table). 
Model chl square 2=113.0, p<0.0001 
AGE GENDER CHOL DUR ST-D DHR2 
Risk Ratio 1.04 2.16 1.01 0,886 1.71 0.997 
p 0.0001 0.001 0,0002 0.003 0.03 0.72 
A similar lack of significance was observed when quartUes of AHR2 were substituted for 
absolute values in this model. 
Conclusions: A blunted DHR2 is not significant predictor of CE in apparently healthy indi- 
viduals, independent of conventional risk factors. 
1184-138 Diabetes Mellitus and Abnormal Heart Rate Recovery in 
Patients Without Coronary Artery Disease 
Niranian Seshadri, Naveen Acharya, Michael S. Lauar, Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Background: Diabetes mellitus (DM) is associated with autonomic dysfunction. Heart 
rate recovery (HRR) after exercise is an easily obtained measure that correlates with 
decreased parasympathetic function and is known to predict mortality, We sought to 
determine if DM is independently associated with an abnormal HRR. 
Methods: We analyzed 1817 consecutive patients who underwent symptom-limitad 
exercise testing as part of a routine screening program. None had history of coronary dis- 
ease. HRR was defined as a fall in heart rate during the first minute after exercise of_< 12 
beats/minute. DM was defined as a fasting blood glucose _> 126 mg/dl or use of hypogly- 
cemic drugs. 
Results: There were 51 patients (2%) who had DM, while 168 (9%) had an abnormal 
HRR. Increasing blood sugar levels were associated with an abnormal HRR, especially 
at diabetic levels (Figure). Patients with DM were more likely to have an abnormal HRR 
Al=e¢lat len ef  Iac~a l lag  a loe  d Glucose Le'celg ~ Hem Rate Recsvery 
~ I ;~ for ~end = 17, P<O,O001 • 
Blood ~ueo le  L~vo~ (m~)  
Q., " r  
= 
190A ABSTRACTS - Cardiac Function and Heart Failure 
(25% vs 9%, odds ratio [OR] 3.6, 95% CI 1.9 to 6.8, P<0.0001). After adjusting for age, 
gender, smoking, blood pressure, use of antihypartensive drugs, LDL, HDL, triglycaddas, 
white blood count, platalet count, TSH, hemoglobin, asthma, use of bronchodilators, 
body mass index, and actual blood sugar level, DM remained independently associated 
with an abnormal HRR (adjusted OR 2.1, 95% CI 1.0 to 4.1, P=O.04). After further adjust- 
ing for exercise capacity, the association was attenuated (adjusted OR 1.9, 95% CI 1.0 to 
3.9, P=0.06). Conclusion: DM is associated with a higher likelihood of an abnormal 
HRR. 
1184-139 The Exerc ise To lerance Test Predicts Future 
Cardiovascular and Al l -Cause Death in Asymptomatic 
Women 
Samia Mora, Yadong Cui, Maura K, Whiteman, Jodi A. Flaws, Roger S. Blumenthal, 
Johns Hopkins Medical Institutions, Baltimore, Maryland, University of Maryland School 
of Medicine, Baltimore, Maryland. 
Background: Cardiovascular disease (CVD) is the leading cause of death in women, yet 
the prognostic significance of exercise tolerance tests (ETTs) in asymptomatic women is 
unknown. We investigated the value of ETTs in predicting future CVO and all-cause mor- 
tality in a low risk population of women. 
Methods: From 1972 to 1976, 2,001 women between ages 40-80 years, without prior 
myocardial infarction, angina or claudication, underwent Bruce protocol E'ITs in the 
baseline evaluation for the Lipid Research Clinics Prevalence Study. Abnormal (ABNL) 
ETTs had >lmm ST depression or elevation, ventdcular tachycardia, or exercise toler- 
anca less than 6 minutes. Negative (NEG) ETTs had no ST changes, lasted ->6 minutes, 
and met target heart rate. Inconclusive (INC) E'l-I's had no ST changes, lasted ->6 min- 
utes, but did not meat target heart rate. 
Results: Dudng an average 20-year follow-up, 30.2% of women with ABNL ETTs died 
versus 21.6% of those with INC ETTs and 13.3% with NEG E'ITs. Women with ABNL and 
INC ETTs were at significantly increased risk for CVD death compared to those with NEG 
ETFs (age-adjustad RR 2.4 and 2.6, respectively) and for all-cause death (RR 1.4 and 
1.7, respectively). In addition, the negative predictive value of the baseline ETr for long- 
term CVD death was 97%. 
Conclusion: In a low risk population of women without cardiovascular disease, an 
abnormal or inconclusive E'l-r was a strong predictor of future cardiovascular mortality, 
su~lestin~l that these women could benefit from a~l~lressive risk factor control. 
ETT n Deaths (%) CVD Death RR All-Cauea Death RR 
(98% Cl) (g5% Cl) 
ABNL 692 30.2 2.4 (1.6-3.6) 1.4 (1.1-1.8) 
INC 116 21.6 2.6 (1.3-5.4) 1.7 (1.1-2.5) 
NEG 1193 13.3 1.0 1.0 
1184-140 The Value of  Exerc ise  E lec t rocard iography  in Women 
With Chest Pain: Comparison With Exercise 
Echocardiography 
Ezra A. Amsterdam, Manish Patel, Jagdeep Mahrok, University of California, Davis, 
Ca/ifomia. 
BACKGROUND: The appropriate initial stress test for evaluating symptoms suggestive 
of coronary artery disease (CAD) in women is controversial. Because of a higher rate of 
false positive responses in women than men on standard exercise (Ex) electrocardio- 
graphy (ECG), it has been proposed that the initial test in women should be a stress 
imaging modality. In current practice, a negative evaluation by the latter approach usually 
obviates the need for further invasive testing for CAD. 
METHODS: To address this question, we analyzed the results of simultaneous Ex 
echocardiograms (Echo) and Ex ECG performed in women with no known cardiac dis- 
ease as part of the initial evaluation for chest pain suggestive of CAD. All patients (pts) 
had a normal resting ECG and adequate exercise capacity by history. All tests were 
symptom-limited utilizing a Bruce protocol. A positive Ex Echo was defined as an exer- 
cise-induced regional wall motion abnormality and a positive Ex ECG was defined as Ex- 
induced _>I.0 rsm ST-segment depression. 
RESULTS: The study group comprised 371 consecutive women (mean age 56 yrs [31- 
90]) evaluated by simultaneous Ex Echo and Ex ECG, Ex Echo was positive in 6.0% (22/ 
371) and negative in 94.0% (349/371). Ex ECG was positive in 22.6% (84/371) and neg- 
ative in 77.4% (287/371). In 84.5% (71/84) of pts with positive Ex ECG, Ex Echo was 
negative, suggesting a false postive Ex ECG. In this group of 71 pts, non-Echo Ex test 
data were analyzed for evidence of a false positive or low risk test: _>7 METS, _>95% max 
predicted heart rate, double product >25,000, ST depression <1.5 ram, no Ex-ioduced 
chest pain). Three or more of these factors were present in 83.1% (59/71) of the pts with 
a positive Ex ECG and a negative Ex Echo. 
CONCLUSIONS: These results indicate that 1) Ex ECG was negative and concordant 
with Ex Echo in a large majority of women and 2) >80% of positive Ex ECG associated 
with nag Ex Echo were characterized by multiple low risk indicators consistent with a 
false positive or low risk result. Thus, Ex ECG is an appropriate initial test for evaluating 
women with symptoms suggestive of ischemic heart disease who have a normal resting 
ECG and can exercise. 
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1184-161 Physical Fitness, Smoking, and Long-Term Morta l i ty  
Among Air Force Pilots Who Have Undergone Coronary  
Angiography 
Patrick J. Fitzsimmons, William Kruyer, Michael S. Lauer, Cleveland Clinic Foundation, 
Cleve/and, Ohio, Brooks Air Force Base, San Antonio, Armed Forces. 
Background: Although poor physical fitness and smoking are known correlates of death 
risk, their importance once coronary anatomy is known is less clear. 
Methods: We followed 1257 male US Air Fores pilots (age 43:L-6) for 13 years. None had 
known coronary disease or diabetes and none were taking any cardiovascular or antihy- 
pertensive medications. All underwent exercise testing and coronary angiography. Any 
coronary disease was defined as at least one 50% lesion in a major coronary artery or 
branch. Severe coronary disease was defined as a Duke angiographic prognostic weight 
score > 42 (on a scale of 0 to 95). Poor physical fitness was defined as an estimated 
exercise capacity in the lowest quintile for age decade. 
Results: Any coronary disease was present in 200 men (16%) while 25 (2%) had severe 
disease. There were 596 current smokers (55%). Smokers were more likely to manifest 
poor physical fitness (25% vs. 14%, odds ratio [OR] 2.03, 95% CI 1.52-2.73, P<0.0001). 
After adjusting for age, blood glucose, blood pressure, cholesterol level, chronotropic 
response, and the angiographic sevedty of coronary disease, smoking remained an inde- 
pendent correlata of poor physical fitness (adjusted OR 1.78, 95% CI 1.31-2.43, 
P=0.0002). During follow-up there were 51 deaths. In univadate analyses, death was 
associated with poor physical fitness (Quintile 1 :Quintite 5 death rates 8% vs. 2%, hazard 
ratio [HR] 3,08, 95% CI 1.15-8.28, P=0,03) and with smoking (5% vs. 2%, HR 2.18, 95% 
CI 1.16-4.10, P=0.02). Even after adjusting for age, glucose, cholesterol, blood pressure, 
chronotropic response, and angiogrephic results, independent predictors of death 
included poor physical fitness (adjusted HR 2.35, 95% CI 1.22-4.53, P=0.01) and smok- 
ing (adjusted HR 1,90, 95% CI 1.00-3,59, P=0.05). There was no interaction between 
smoking and physical fitness for prediction of death. 
Conclusions: In this cohort of otherwise healthy men, smoking was independently cor- 
related with poor physical fitness, even after taking into account coronary angiographic 
findings. Both smoking and poor physical fitness were independently predictive of long 
term mortality. 
1184-162 Prognost i c  Value of  Exerc ise TesUng in Pat ients  With 
End Stage Renal  Disease 
Bhuoinder Sinoh, Martin J. Schreiber, Eugene H. Bleckstone, Claire E. Pothier Shader, 
Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: The prognostic value of exercise testing in patients with end-stage renal 
disease (ESRD) has not been well described. 
Methods: We followed for 6 years 266 patients (age 49+12, 70% male) with ESRD who 
underwent symptom-limited exercise tests, Poor fitness was defined as poor functional 
capacity for age and gender based on a previously validated scheme. Chronotropic 
incompetence was failure to use 80% of heart rate reserve in patients not using beta- 
blockers. Heart rate recovery was the decrease in heart rate in the first minute after exer- 
cise; < 12 was abnormal, 
Results: There were 84 deaths; 65 later had renal transplants. Thirty-seven (14%) had 
heart failure, while 30 (14%) had prior CABG, and 56 (21%) bad pdor renal transplants- 
tion. Poor fitness was noted in 89 (33%), chronotropic incompetence in 140 (53%), and 
abnormal heart rate recovery in 139 (53%). Univariate predictors of death included poor 
fitness (48% vs. 23%, P<0.O001 ), chmnotmpic incompetence (41% vs. 21%, P<0.0001), 
and abnormal heart rate recovery (39% vs. 24%, P<0.0001). After adjusting for age, gen- 
der, coronary disease, heart failure, insulin, prior renal transplantation, and later trans- 
plantation (as a time-dependent covariate), predictors of death included poor fitness 
(adjusted hazard ratio [HR] 1.9, 95% CI 1.2-3.0, P=0.005) and ehronotropic incompe- 
tence (HR 2.2, 95% CI 1.4-3.5, P=0.O01). (Figure) 
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Conclusion: Impaired functional capacity and chronotropic incompetence are predictive 
of death in patients with ESRD. 
